protease
deficiency
plasma
patient
cystic
fibrosis
reduced
reaction
plasma
patient
cystic
fibrosis
protease
activity
plasma
assayed
using
assay
modified
carrying
reaction
presence
absence
benzamidine
competitive
inhibitor
trypsin
like
protease
parameter
assay
described
detail
using
assay
earlier
demonstration
deficiency
protease
activity
plasma
patient
cystic
fibrosis
confirmed
activity
corrected
nonspecific
hydrolysis
benzamidine
expressed
nanomoles
methylumbelliferone
released
per
milliliter
plasma
standard
condition
activity
plasma
activated
chloroform
ellagic
acid
control
obligate
heterozygote
patient
cystic
fibrosis
identical
result
obtained
unactivated
plasma
used
data
demonstrate
judicious
use
specific
inhibitor
benzamidine
might
useful
assaying
low
level
protease
activity
crude
system
